Systemic absorption of topical lidocaine
โ
Bryan J. Campbell; Michael Rowbotham; Pamela Stitzlein Davies; Peyton Jacob III;
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 103 KB
Topical lidocaine has been recently marketed as a new treatment for postherpetic neuralgia. The aim of our study was to characterize the absorption profile of and systemic exposure to lidocaine from patch and gel formulations in normal volunteers, patients with post-herpetic neuralgia, and patients